Clinical Trials in Atlanta

Showing 1821-1840 of 9,468 trials

A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome

NCT03837483

This is an open-label, single arm study to evaluate the cryopreserved formulation of OTL-103 Gene Therapy. OTL-103 consists of autologous CD34+ hematopoietic stem cells in which the gene encoding for the Wiskott-Aldrich Syndrome is introduced by means of a third generation lentiviral vector.

Wiskott-Aldrich Syndrome

Fondazione Telethon10 participantsStarted Jan 2019

Atlanta, Georgia, United States • Milan, Italy

COMPLETEDNA< 1 mile

OP5-005 Using Omnipod 5 in Adults With Type 2

NCT05815342

This is a single arm, multi-center, prospective study that will evaluate the safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes requiring insulin therapy.

Type2 Diabetes

Insulet Corporation343 participantsStarted Apr 2023

Los Angeles, California, United States • Santa Barbara, California, United States • Aurora, Colorado, United States +18 more locations

A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome

OP5-005 Using Omnipod 5 in Adults With Type 2

Find Trials by Condition in Atlanta

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis

Effect of Personalized Pain Coaches After Orthopaedic Surgery for Patients With Sports Medicine Injuries

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

A Registry for Participants With Chronic Hypoparathyroidism

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

CERAMENT™| Bone Void Filler Device Registry

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Performance of MOTO Medial® Unicompartmental Knee Arthroplasty

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

Anti-viral Therapy in Alzheimer's Disease